Please login to the form below

Not currently logged in


This page shows the latest VLS-101 news and features for those working in and with pharma, biotech and healthcare.

Merck strengthens oncology pipeline with $2.75bn VelosBio deal

Merck strengthens oncology pipeline with $2.75bn VelosBio deal

The deal will give Merck control of VLS-101, an antibody-drug conjugate. ... In the DLBCL group, four of the five patients who were treated with VLS-101 had objective responses.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
integrated medhealth communication

imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...

Latest intelligence

Understanding behaviour change: A Porterhouse Insights specialism
Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...